NO981268D0 - Chemokininhibitor - Google Patents

Chemokininhibitor

Info

Publication number
NO981268D0
NO981268D0 NO981268A NO981268A NO981268D0 NO 981268 D0 NO981268 D0 NO 981268D0 NO 981268 A NO981268 A NO 981268A NO 981268 A NO981268 A NO 981268A NO 981268 D0 NO981268 D0 NO 981268D0
Authority
NO
Norway
Prior art keywords
chemokininhibitor
Prior art date
Application number
NO981268A
Other languages
English (en)
Other versions
NO981268L (no
Inventor
Craig A Smith
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of NO981268D0 publication Critical patent/NO981268D0/no
Publication of NO981268L publication Critical patent/NO981268L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO981268A 1995-09-29 1998-03-20 Chemokininhibitor NO981268L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53732495A 1995-09-29 1995-09-29
US57571595A 1995-12-20 1995-12-20
PCT/US1996/015385 WO1997011714A1 (en) 1995-09-29 1996-09-26 Chemokine inhibitor

Publications (2)

Publication Number Publication Date
NO981268D0 true NO981268D0 (no) 1998-03-20
NO981268L NO981268L (no) 1998-05-29

Family

ID=27065462

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981268A NO981268L (no) 1995-09-29 1998-03-20 Chemokininhibitor

Country Status (10)

Country Link
US (1) US5871740A (no)
EP (1) EP0862449A4 (no)
JP (1) JPH11514861A (no)
KR (1) KR19990063653A (no)
AU (1) AU713661B2 (no)
CA (1) CA2232706A1 (no)
IL (1) IL123653A0 (no)
NO (1) NO981268L (no)
NZ (1) NZ320889A (no)
WO (1) WO1997011714A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495515B1 (en) 1995-04-19 2002-12-17 Viron Therapeutics, Inc. Chemokine binding protein and methods of use therefor
EP1034789A1 (en) * 1996-05-22 2000-09-13 University Of Alberta Type-2 chemokine binding proteins and methods of use therefor
WO1997044054A2 (en) * 1996-05-22 1997-11-27 University Of Alberta Type-2 chemokine binding proteins and methods of use therefor
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6589933B1 (en) 1999-04-02 2003-07-08 Viron Therapeutics, Inc. Myxoma chemokine binding protein
AU1174402A (en) 2000-10-11 2002-04-22 Viron Therapeutics Inc Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
WO2002046214A2 (en) * 2000-12-04 2002-06-13 Viron Therapeutics Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US20040241163A1 (en) * 2001-04-05 2004-12-02 Thomas Shenk Compositions and methods for treating inflammation and related conditions
US20020165161A1 (en) * 2001-05-04 2002-11-07 Surromed, Inc. Chemokine-binding proteins for treating congestive heart failure
AU2002346056A1 (en) * 2001-07-12 2003-01-29 Immunex Corporation Viral proteins capable of binding lar
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
KR101170653B1 (ko) 2002-08-12 2012-08-03 제네렉스, 인코포레이티드 폭스바이러스 및 암과 관련된 방법 및 조성물
AU2003300680A1 (en) * 2002-12-10 2004-07-09 Centre National De La Recherche Scientifique Cnrs Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
GB0304531D0 (en) * 2003-02-27 2003-04-02 Isis Innovation Treatment
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
EP1933857A2 (en) * 2005-09-07 2008-06-25 Jennerex Biotherapeutics ULC Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
JP2009529917A (ja) * 2006-03-22 2009-08-27 ヴァイラル ロジック システムズ テクノロジー コーポレーション 標的ポリペプチドの同定方法および免疫学的疾患の治療のためのその使用
KR20080084528A (ko) * 2007-03-15 2008-09-19 제네렉스 바이오테라퓨틱스 인크. 종양살상형 백시니아 바이러스 암 치료
ES2671570T3 (es) 2009-09-14 2018-06-07 Sillajen Biotherapeutics, Inc. Terapia combinada contra el cáncer con virus oncolítico de vaccinia
KR101942237B1 (ko) 2011-01-04 2019-01-25 신라젠(주) 종양 항원에 대한 항체의 생산 및 종양용해 우두 바이러스의 투여에 의한 종양 특이적 보체 의존적 세포독성의 생산

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157110A (en) * 1988-08-20 1992-10-20 The Government Of The United States Of America Synthetic, anti-complement protein
WO1990010693A1 (en) * 1989-03-08 1990-09-20 Health Research, Inc. Recombinant poxvirus host selection system
GB8915870D0 (en) * 1989-07-11 1989-08-31 Nat Res Dev Dna coding for a polypeptide signal sequence in vaccinia virus
CA2146328C (en) * 1992-11-10 2011-08-09 Richard Horuk C-c ckr-1, c-c chemokine receptor
DE69433648T2 (de) * 1994-08-23 2005-02-17 Human Genome Sciences, Inc. Menschliche chemokin-polypeptide

Also Published As

Publication number Publication date
CA2232706A1 (en) 1997-04-03
AU7372596A (en) 1997-04-17
AU713661B2 (en) 1999-12-09
WO1997011714A1 (en) 1997-04-03
JPH11514861A (ja) 1999-12-21
US5871740A (en) 1999-02-16
EP0862449A4 (en) 1998-11-11
NZ320889A (en) 2000-09-29
NO981268L (no) 1998-05-29
KR19990063653A (ko) 1999-07-26
IL123653A0 (en) 1998-10-30
EP0862449A1 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
BR9609301A (pt) Cetoenois dialquil-halogenofenil-substituídos
BR9609171A (pt) Fenilpiridazinonas
NO981268D0 (no) Chemokininhibitor
ATA135896A (de) Skibob
BR9607795A (pt) Fucopeptídeos
BR9605387A (pt) 1-azinil-tetrazolinonas
BR9603509A (pt) Piperidinilmetiloxazolidinonas
ATE198470T1 (de) Alkenyl-benzoylguanidine
BR9605050A (pt) Filatório
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
BR9503866A (pt) Autolabor
BR9501643A (pt) Helistato
BR7500809U (pt) Tele-negocios
BR9501962A (pt) Lotofone
FIU950245U0 (fi) Tyngd- och laeslinjal
FI954444A0 (fi) Stroemkaellsenhet
FI951037A0 (fi) Fjaedringssystem foer snoeskoter
BR7500825U (pt) Chutegol
BR9502885A (pt) Casarreal
BR7500703U (pt) Rodopratic
BR7500192U (pt) Parasitofiltro
BR7501298U (pt) Torre-audio-visual
FIU950526U0 (fi) Graesavlaegsnare
FIU950261U0 (fi) Braenslepack

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application